DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $204,931 | -0.2% | 826 | -3.5% | 0.06% | +7.7% |
Q2 2023 | $205,440 | -13.8% | 856 | -9.5% | 0.05% | -14.8% |
Q1 2023 | $238,430 | -13.9% | 946 | -9.3% | 0.06% | -16.4% |
Q4 2022 | $276,833 | +25.3% | 1,043 | +16.7% | 0.07% | +19.7% |
Q3 2022 | $221,000 | -9.1% | 894 | -6.9% | 0.06% | -11.6% |
Q2 2022 | $243,000 | -11.0% | 960 | +3.3% | 0.07% | -8.0% |
Q1 2022 | $273,000 | -15.5% | 929 | -5.5% | 0.08% | -31.8% |
Q4 2021 | $323,000 | +5.9% | 983 | -2.0% | 0.11% | -9.8% |
Q3 2021 | $305,000 | -8.4% | 1,003 | -7.4% | 0.12% | -9.0% |
Q2 2021 | $333,000 | +29.6% | 1,083 | -5.2% | 0.13% | +16.5% |
Q1 2021 | $257,000 | +5.3% | 1,143 | +10.4% | 0.12% | +5.5% |
Q4 2020 | $244,000 | +4.3% | 1,035 | 0.0% | 0.11% | -19.9% |
Q3 2020 | $234,000 | +2.2% | 1,035 | -6.8% | 0.14% | -3.5% |
Q2 2020 | $229,000 | -5.4% | 1,110 | -36.6% | 0.14% | -35.9% |
Q1 2020 | $242,000 | -23.7% | 1,750 | -10.0% | 0.22% | +13.4% |
Q4 2019 | $317,000 | -5.4% | 1,945 | -19.6% | 0.19% | -14.2% |
Q3 2019 | $335,000 | -8.2% | 2,420 | -5.1% | 0.23% | -12.7% |
Q2 2019 | $365,000 | +8.3% | 2,550 | 0.0% | 0.26% | +0.4% |
Q1 2019 | $337,000 | +10.1% | 2,550 | -7.3% | 0.26% | +7.5% |
Q4 2018 | $306,000 | – | 2,750 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |